On July 21, 2015, the Federal Circuit reached a momentous decision in the case of Amgen vs. Sandoz. The significance of this ruling goes well beyond the rights of these particular manufacturers, as the decision marks the first step toward clarifying the regulatory path for U.S. biosimilar manufacturers.
Watch the webinar now to learn how an innovative approach can improve the clinical trial experience and move medicine forward.
The relationships and considerations of bead structure, pore structure, surface chemistries and ligand design on affinity resin performance targets.
This webinar will cover multivariate data analysis applied to Raman data.